Research Article
Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses
Table 3
The percentage of antibody binding to equine MSCs prior to and after MSC administration.
| | Study horses | | Tendon | Eye | IV | n | 4 | 5 | 5 | 5 | MSC source | BM-MSC | Ad-MSC | BM-MSC | Ad-MSC | | Before (%) | After (%) | Before (%) | After (%) | Before (%) | After (%) | Before (%) | After (%) |
| Minimum | 0.00 | 19.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Maximum | 0.00 | 48.56 | 1.38 | 12.00 | 4.96 | 13.42 | 1.21 | 6.70 | Median | 0.00 | 41.68 | 0.38 | 0.00 | 0.21 | 0.00 | 0.24 | 1.09 | Average | 0.00 | 37.90 | 0.53 | 4.53 | 1.46 | 3.25 | 0.43 | 1.93 |
|
|
Significant difference between % antibody binding before MSC administration and % antibody binding after MSC administration.
|